AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06767826 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Salutogenesis Models
Description: On the basis of the Salutogenesis Model, this study is based on the development of individuals' internal and external resources for game addictions and strengthening their sense of integrity. It has been determined that digital game addiction and problematic internet use in adolescents form the basis of seven problems. These problems have been identified as mental health, vision, pain, sleep and rest patterns, nutrition, social contact and physical activity. Encouraging behavioral changes regarding internet use and teaching adolescents how to deal with these problems becomes a necessity in today's technology. In the literature, counseling has been provided for families and adolescents to prevent digital game addiction in adolescents.
Study NCT06769763 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: My Journey with MS application
Description: This is an Arabic application for MS patients that provides them with information about self-care like nutrition, exercise, mental health, and self-management, in addition to other features like symptom tracking and medication reminders.
Study NCT06768125 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Hypofractionated Radiation Therapy
Description: 95% PGTVp: 33 Gy in 3.3 Gy per session for 10 sessions, and 95% PTV1: 25 Gy in 1.5 Gy per session for 10 sessions, with an interval of 1-2 weeks, for a total of 2 cycles.
Study NCT06768736 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Personalised early warning system
Description: Early warning system personalised forecasting messages
Study NCT05445544 — intervention group
Intervention type: OTHER
Intervention: Observational studies, The diagnosis was preeclampsia
Description: Observational studies, The diagnosis was preeclampsia
Study NCT05501496 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: casting
Description: casting with long leg cast
Study NCT05928429 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Elasto-Gel™ mitts for hands: TM7008, and slippers for feet: SL3000; Southwest Technologies, Inc., North Kansas City, MO, USA
Description: Patients in the experimental arm will wear glycerine-containing Elasto-Gel™ gloves and socks (Elasto-Gel™ mitts for hands: TM7008, and slippers for feet: SL3000; Southwest Technologies, Inc., North Kansas City, MO, USA) over a disposable glove and sock liner secured by Velcro at the wrist and ankle on their hands and feet from 15 minutes before paclitaxel administration to 15 minutes after the infusion is complete (90 minutes in total).
Study NCT06244056 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Stellate Ganglion Block
Description: A stellate ganglion block is performed by a medical professional in a sterile setting. Firstly Position of patient: Semi-lateral decubitus position, with the neck turned contralateral. Using Probe of ultrasound: Linear 6-13 MHz to guide the needle to the stellate ganglion , The skin at the injection site is cleaned with an antiseptic solution to reduce the risk of infection. A local anesthetic is injected into the skin and deeper tissues to numb the area. Needle:25G 1.5 inch or 22G 3.5 inch is inserted through the skin and deeper tissues until it reaches the stellate ganglion.Once the needle is in the correct position, 3-5 mL of local anesthetic (0.25-0.5% bupivacaine) The procedure typically takes about 15-20 minutes.
Study NCT05001516 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LM-302
Description: All subjects will be administered every 3 weeks (1 cycle=21 days) with a dose of LM-302 intravenous infusion on day 1 until meet the criteria of treatment discontinuation or withdraw, whichever occurs earlier.
Study NCT05819814 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Disclosure of high polygenic risk result for coronary artery disease
Description: The disclosure of a high polygenic risk result for coronary artery disease involves a clinical report coupled with a virtual meeting with a genetic counselor.
Study NCT05899465 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: A single preoperative intravenous dose and per os treatment postoperatively day 1 through 4
Study NCT05899465 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: A single preoperative intravenous dose and per os treatment postoperatively day 1 through 4
Study NCT05238870 — intervention group
Intervention type: OTHER
Intervention: Interviews for the needs analysis. No intervention.
Description: To develop the education and training package, a needs-analysis is necessary. The clinicians' training needs will be established through interviews.
Study NCT05555524 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Baby oil
Description: Before each application~* Hand hygiene will be done~* Skin care will be done to the affected area and the area is thoroughly dried.~* Participants will wear a hospital gown and seated comfortably on their bed.~* Gentle massage with the cool baby oil will be applied on the itching area and is continued for 15-20 min.~* Message will be applied for three times a week before each hemodialysis session for 12 weeks
Study NCT05555524 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Before each application~* Hand hygiene will be done~* Skin care will be done to the affected area and the area is thoroughly dried.~* Participants will wear a hospital gown and seated comfortably on their bed.~* Gentle massage with the cool distilled water will be applied on the itching area and is continued for 15-20 min.~* Message will be applied for three times a week before each hemodialysis session for 12 weeks
Study NCT05085821 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HEART
Description: In an augmented reality environment, the patient receives visual feedback in synchrony with their cardiac-cycle (HEART)
Study NCT05085821 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Placebo
Description: In an augmented reality environment, the patient receives visual feedback out-of-synchrony with their cardiac cycle (Placebo)
Study NCT05043701 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Personalized drug combination
Description: A personalized drug combination will be prescribed to each patient based on the functional drug screen
Study NCT04705064 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Prediction of postoperative acute kidney injury using an artificial intelligence
Description: The performance of an artificial intelligence model to predict postoperative acute kidney injury will be tested prospectively.
Study NCT05502614 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neuromodulation
Description: Transcutaneous stimulation of the dorsal genital nerve using the Innocon Medical UCon device to provide on demand relief of bladder spasms
Study NCT06382038 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mobile venous thromboembolism application (mVTEA)
Description: mVTEA will assist in the management of patients during the post-hospitalization follow-up phase. The mVTEA's doctor terminal automatically sends venous thromboembolism (VTE)-related health education materials in different frequencies and contents based on the patient's knowledge of VTE prevention and treatment, as well as their risk of thrombosis and bleeding during follow-up. In addition, thrombosis physicians on the mVTEA's doctor terminal can deliver health education to patients based on their condition. This can be done through the mVTEA doctor-patient communication module, which includes text, voice, and video communication.
Study NCT06096324 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Job announcements plus educational sessions, mentoring, a micro-grant, and behavioral economic text messages
Description: Participants will receive job announcements plus educational sessions, mentoring, a micro-grant, and behavioral economic text messages.
Study NCT06096324 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Job announcements
Description: Participants will receive job announcements only.
Study NCT04962399 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Enzyme linked immunosorbent assay
Description: Serum N / OFQ and IL-6 levels were detected，and the genotype and allele frequencies of rs1800796 in IL-6 gene were determined.
Study NCT05502419 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Neural slump mobilization
Description: Slump stretching will be performed with the patient in the long sitting position with the patient's feet against the wall to assure the ankle remained in 0 degree dorsiflexion. The therapist will apply over pressure to the cervical spine flexion to the point where the patient's symptoms will be reproduced. The position will be held for 30 s. A total of 5 repetitions will be completed.
Study NCT05502419 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physical Therapy
Description: Moist heat with hydro collator pack, Maitland Mobilization for Lumbar spine, Therapeutic exercise: Core stability exercises
Study NCT05502419 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conventional Physical Therapy
Description: Moist heat with hydro collator pack, Maitland Mobilization for Lumbar spine, Therapeutic exercise: Core stability exercises
Study NCT05842213 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AVT05 (proposed biosimilar to golimumab)
Description: AVT05 is a recombinant human IgG1қ mAb developed as a subcutaneous injection
Study NCT05842213 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: AVT05 (proposed biosimilar to golimumab)
Description: AVT05 is a recombinant human IgG1қ mAb developed as a subcutaneous injection
Study NCT05842213 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Simponi (Golimumab)
Description: Simponi (Golimumab) is a recombinant human IgG1қ mAb developed as a subcutaneous injection
Study NCT06075797 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PediQUEST ResPOND
Description: PPC teams will have access to feedback reports and the PQ-ResPOND checklist (standardized framework to diagnosis and treatment of recurrent pain behaviors in children with severe neurologic impairment).~Integration of the PPC team into care will be achieved through (i) initial consultation (goals: identify treatment goals, and address recurrent pain), and (ii) follow-up: the team will contact or visit the family in response to feedback reports or for treatment monitoring purposes.
Study NCT06452147 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nerve block+standard anesthesia
Description: 1. Receive nerve block as soon as possible after randomization;~2. Ultrasound-guided nerve block is recommended, with the iliacfascia block recommended as the blocking site;~3. It is recommended to use 1.33% bupivacaine liposome (long-acting), and the maximum dose should not exceed 133mg; or regular local anesthetic (bupivacaine or ropivacaine, etc.) with electronic analgesic pumping infusion; or multiple single injections of regular local anesthetics should be used to maintain the continuity of nerve block effect.
Study NCT06452147 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine+standard anesthesia
Description: 1. Subjects randomly assigned to Lidocaine Group (Group L) will be given ECG monitoring, oxygen saturation monitoring, blood pressure monitoring and an open intravenous route on the morning of the surgery. It is recommended to start the infusion of Lidocaine as soon as possible in the ward.~2. It is recommended to use portable electronic infusion pump for drug delivery. The loading dose is 1mg/kg, and the maintenance dose range is 1\~2mg/kg/h. The specific dosage is determined by the anesthesiologist based on the patient's condition. The infusion ends when the patient leaves the Post-anesthesia care unit after surgery, and the infusion time and total amount should be recorded.
Study NCT06452147 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine liposome
Description: 1.33% bupivacaine liposome
Study NCT06452147 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided nerve block
Description: Ultrasound-guided nerve block
Study NCT06537011 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK112
Description: 1. The patients are given AK112 combined with AP regimen every 3 weeks for 3 cycles before operation.~2. After the neoadjuvant therapy ,the patients will be assessed and be commanded surgery.~3.4-6 weeks after the surgery, the patients will be given chemoradiotherapy or radiotherapy alone decided on the conditon after surgery.~4.The participants will receive AK112 for 14 cycles after surgery.
Study NCT05093387 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV
Study NCT05093387 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given IV
Study NCT05093387 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Transferrin Receptor-Targeted Liposomal p53 cDNA
Description: Given IV
Study NCT05413525 — intervention group
Intervention type: PROCEDURE
Intervention: ultrasound-guided manual vacuum aspiration (USG- MVA)
Description: USG-MVA was carried out as an outpatient day procedure. Women was given a 400μg oral misoprostol tablet 2-3 hours before the procedure. All patients will be given 500mg naproxen orally an hour before the procedure. During the USG-MVA, all the women were placed in the lithotomy position and aseptically dressed. Speculum was performed to visualize the cervix with PCB performed. USG-MVA was performed using a 60ml charged syringe with a flexible curetteattached to it. Transabdominal USG during MVA was performed. During the procedure, local lidocaine gelwas applied to the cervical canal and over the end of the MVA catheter tip during the insertion.The USG-MVA was stopped as soon as USG confirmed that the uterine cavity was empty, defined as a thin endometrial lining with no evidence of retained products of conception.
Study NCT05124106 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Raman Spectrometry
Description: Bladder tumor is examined with Raman spectrometry during endoscopy
Study NCT05046522 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palmitoylethanolamide sold as Levagen +
Description: Investigational product to be taken as a 700mg (2 x 350mg) dosage at onset of migraine. If unresolved at 2 hours post onset of migraine, a second dose of 700mg (2 x 350mg) is to be taken.
Study NCT05046522 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo comparator - maltodextrin and microcrystalline cellulose mix
Description: Placebo product to be taken as a 700mg (2 x 350mg) dosage at onset of migraine. If unresolved at 2 hours post onset of migraine, a second dose of 700mg (2 x 350mg) is to be taken.
Study NCT05798039 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ENRICH
Description: Participants will receive additional heart health-focused materials and guidance in sessions with their nurse home visitor. The nurse will help them choose and work towards behavior goals to support their health. This will include goals for activity, diet, weight, blood pressure, diabetes, smoking, social relationships, sleep, parenting, and getting health care.
Study NCT05347966 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Brain Health PRO
Description: BHPro is a 45-week, multidomain web-based formal educational program which has been designed to increase dementia literacy, convey best available evidence for lifestyle changes that can mitigate dementia risk, and foster engagement toward one's own brain health.
Study NCT05470881 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atropine Sulfate
Description: Administration of one drop QD on both eyes for 14 days.
Study NCT05287698 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cold vapor
Description: Before surgery, socio-demographic data of the patients, ASA and Mallampati scores, sore throat level, and dysphagia level will be recorded. After surgery, patients will be evaluated in the recovery room for their suitability to participate in the study with the Ramsay sedation scale and the Modified Aldrete Scale. Cold vapor will be applied to the patients for 15 minutes in the recovery room during the postoperative period. The parameters to be set on the device for the cold vapor to be applied to the patients in the early postoperative period will be vapor intensity level 5, air blowing intensity 5, heater intensity 1 (+10C), and timer 15 minutes. The patients will be evaluated by the researchers in terms of sore throat and dysphagia before and 15 minutes after the cold vapor application in the recovery room and at the 6th, 12th, and 24th hours after the cold vapor application in the postoperative service.
Study NCT05508386 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: MATLAB-based interface, showing 50 EEG traces, classification of the EEG-pattern as Burst Suppression possible, yes, no.
Description: A software environment (MATLAB) was developed, that allows the international experts to access the data set and score the traces pseudonymously. This MATLAB-based interface shows 50 EEG traces. A representative dataset was composed, consisting of definite Burst Suppression patterns (positive control), intraoperative EEG without Burst Suppression patterns (negative control), and patterns indicating different manifestations of a possible Burst Suppression-like pattern.
Study NCT06009640 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intraoperative neurophysiological monitoring with Nicolet Endeavor IOM Machine
Description: Integration of intraoperative neurophysiological monitoring (IONM) into laparoscopic decompression surgery to protect pelvic nerves by continuously monitoring when they are at risk during surgery.
Study NCT05019274 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Culinary Medicine Intervention
Description: Participants randomized to the Culinary Medicine intervention will complete a series of 6 virtual culinary medicine cooking classes (1 class per month for 6 months). Virtual sessions will be delivered via Zoom using a combination of large group instruction and small group break-out sessions in which participants prepare a recipe in their home kitchen with the virtual assistance from trained group facilitators. After preparing the dish, participants will enjoy the dish they prepared and report-back to the large group about their dish and experience. Classes will be conducted in English and Spanish with language-concordant instructors and facilitators.
Study NCT05019274 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care Nutrition Visits
Description: Participants randomized to standard of care nutrition visits will complete a series of 6 nutrition visits (1 session per month for 6 months) led by bilingual (English/Spanish) dieticians. Sessions will consist of a mix of individual and small group sessions per standard of care in the clinic.
Study NCT06013501 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: puppet show
Description: puppet show to the child before and during subcutaneous application
Study NCT04762485 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Humanized CD7 CAR-T cells
Description: Split intravenous infusion of CD7 CAR-T cells \[dose escalating infusion of (0.5-10)x10\^6 CD7 CAR-T cells/kg
Study NCT06328816 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: routine rehabilitation treatment
Description: The routine rehabilitation treatment included intervention for risk factors (such as blood pressure, blood lipids, and blood glucose control, restriction of smoking and alcohol, exercise, etc.) Besides, the patients with stable vital signs were scheduled for specialized rehabilitation training upon enrollment, and targeted rehabilitation programs were selected, conducted by experienced rehabilitation therapists.
Study NCT06328816 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: routine rehabilitation treatment
Description: The routine rehabilitation treatment included intervention for risk factors (such as blood pressure, blood lipids, and blood glucose control, restriction of smoking and alcohol, exercise, etc.) Besides, the patients with stable vital signs were scheduled for specialized rehabilitation training upon enrollment, and targeted rehabilitation programs were selected, conducted by experienced rehabilitation therapists.
Study NCT06328816 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Computer-assisted Cognitive Function Training
Description: Based on the patient's cognitive impairment assessment results, the training content includes Attention game training, Executive function program training, Logical reasoning training, Agility training, Memory training. The training is conducted seven days a week, once a day, for a duration of 30-45 minutes per session
Study NCT04949646 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic Intraoperative Neuromonitoring
Description: Pelvic Intraoperative Neuromonitoring (pIONM) allows mapping of the pelvic autonomous plexus during total mesorectal excision (TME).
Study NCT05083325 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oseltamivir 75mg Test Drug capsules
Description: Investigational Medicinal Product
Study NCT05083325 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oseltamivir 75mg capsules Reference Product capsules
Description: Tamiflu (Roche Pharma (Switzerland) AG, Basel)
Study NCT05897801 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MeMed BV®
Description: One blood sampling of 3ml will be drawn on the first day for the performance of the MeMed BV® test. Two rectal swabs will be taken for determining the MDRO gut colonization. Patient information regarding the specific respiratory tract infection and the treatment regimen being prescribed will be recorded in the eCRF made specifically for this trial.